CTi Biopharma Corp (NASDAQ:CTIC)

4.90
Delayed Data
As of May 18
 +0.29 / +6.29%
Today’s Change
2.45
Today|||52-Week Range
4.99
+82.84%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues60.1M16.1M57.4M25.1M
 
 
 
 
 
Cost of Goods Sold895.0K950.0K546.0K364.0K
 
 
 
 
 
Depreciation And Amortization1.1M990.0K831.0K717.0K
 
 
 
 
 
 
Operating ExpensesGross Income58.1M14.2M56.0M24.1M
 
 
 
 
 
General Expenses119.7M130.6M110.3M61.4M
 
 
 
 
 
Other Operating Expenses2.7M253.0K823.0K0.00
 
 
 
 
Research And Development64.6M76.6M65.0M32.9M
 
 
 
 
 
Total Operating Expenses124.5M132.8M112.5M62.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-64.4M-116.7M-55.1M-37.3M
 
 
 
 
 
Extraordinary Credit--0.005.9M0.00
 
 
Extraordinary Charge-21.9M-1.2M0.00-2.3M
 
 
 
 
Interest Expense On Debt2.7M2.5M2.8M2.0M
 
 
 
 
 
Other Expenses-5.3M-392.0K-963.0K823.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-94.2M-120.8M-53.0M-40.8M
 
 
 
 
 
Minority Interest-862.0K-1.3M-944.0K-161.0K
 
 
 
 
 
Preferred Dividend-2.6M-3.2M0.00-4.4M
 
 
 
 
Net Income-93.4M-119.4M-52.0M-40.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS14.9M18.8M27.9M36.4M
 
 
 
 
 
Shares To Calculate EPS Diluted14.9M18.8M27.9M36.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$6.50-$6.50-$18.60-$1.24
 
 
 
 
 
EPS Diluted-$6.50-$6.50-$1.86-$1.24